Kühl, Uwe <br/><br/>
Interferon-beta treatment eliminates cardiotropic viruses and improves left ventricular function in patients with myocardial persistence of viral genomes and left ventricular dysfunction.  [electronic resource] 

 -  Circulation  Jun 2003 
 - 2793-8 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Clinical Trial, Phase II; Journal Article 
<br/><br/><label>ISSN: </label>1524-4539 
<br/><br/><label>Standard No.: </label>10.1161/01.CIR.0000072766.67150.51  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adenoviridae--drug effects<br/>Antiviral Agents--therapeutic use<br/>Biopsy<br/>Cardiac Volume--drug effects<br/>Cardiomyopathy, Dilated--complications<br/>Cell Count<br/>Disease Progression<br/>Electrocardiography<br/>Enterovirus--drug effects<br/>Female<br/>Heart--drug effects<br/>Hemodynamics--drug effects<br/>Humans<br/>Interferon-beta--adverse effects<br/>Male<br/>Middle Aged<br/>Myocardium--pathology<br/>Polymerase Chain Reaction<br/>Stroke Volume--drug effects<br/>T-Lymphocytes--pathology<br/>Treatment Outcome<br/>Ventricular Dysfunction, Left--complications